Uterine papillary serous carcinoma: Study of 19 cases

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 79, Issue 1, 1998, Pages 69-73

  Piura, Benjamin ^a   Meirovitz, Mihai ^a   Shmulman, Michael ^a   Yanai Inbar, Ilana ^b   Cohen, Yoram ^b   Dgani, Ram ^c  

^a Unit of Gynecologic Oncology   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c KAPLAN HOSPITAL   (Israel)

Author keywords

Adjuvant therapy; Endometrial carcinoma; Papillary serous carcinoma; Surgical stage

Indexed keywords

CARBOPLATIN; CESIUM 137; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MELPHALAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HYSTERECTOMY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SALPINGOOOPHORECTOMY; UTERUS CARCINOMA;

EID: 0031804299     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00039-6     Document Type: Article

References (25)

1. Hendrickson M.R., Ross J., Eifel P.J., Martinez A., Kempson R.L. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 6:1982;93-108.
2. Abeler V.M., Kjorstad K.E. Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol. 39:1990;266-271.
3. Rosenberg P., Blom R., Hogberg T., Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol. 51:1993;311-315.
4. Kato D.T., Ferry J.A., Goodman A., Sullinger J., Scully R.E., Goff B.A., Fuller A.F., Rice L.W. Uterine papillary serous carcinoma (UPSC): A clinicopathologic study of 30 cases. Gynecol Oncol. 59:1995;384-389.
5. Huang SJ, Berek JS, Fu YS. Pathology of endometrial carcinoma. In: Coppleson M, Monaghan JM, Morrow CP, Tattersall MHN, editors. Gynecologic oncology: fundamental principles and clinical practice. 2nd edn. Edinburgh, London, Melbourne, New York and Tokyo: Churchill Livingstone, 1992:753-74.
6. Goff B.A., Kato D.T., Schmidt R.A., Ek M., Ferry J.A., Muntz H.G., Cain J.M., Tamimi H.K., Figge D.C., Grer B.E. Uterine papillary serous carcinoma: Patterns of metastatic spread. Gynecol Oncol. 54:1994;264-268.
7. Chambers J.T., Merino M., Kohorn E.I., Peschel R.E., Schwartz P.E. Uterine papillary serous carcinoma. Obstet Gynecol. 69:1987;109-113.
8. Shepherd J.H. Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol. 96:1989;889-892.
9. Swinscow TDV. Statistics at square one. 8th edn. Tvistock Square, London: British Medical Association, 1983.
10. Kaplan E.L., Meier P. Non-parameric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
11. Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of radomized clinical trials requiring prolonged observation of each patient. II. Analysis ans examples. Br J Cancer. 35:1977;1-39.
12. Israel Cancer Registry. Cancer in Israel Facts and Figures 1992. State of Israel, Ministry of Health, Department of Epidemiology.
13. Schenker J.G., Tal J. Adenocarcinoma of endometrium in Israel 1960-1968. Cancer. 46:1980;2752-2758.
14. Piura B., Bar-Dayan A., Cohen Y., Yanai-Inbar I., Glezerman M. Endometrial carcinoma in the south of Israel: Study of 231 cases. J Surg Oncol. 66:1997;189-195.
15. Schwartz Z., Dgani R., Lancet M., Kessler I. Uterine sarcoma in Israel: A study of 104 cases. Gynecol Oncol. 20:1985;354-363.
16. Piura B., Rabinovich A., Yanai-Inbar I., Cohen Y., Glezerman M. Uterine sarcoma in the south of Israel: Study of 36 cases. J Surg Oncol. 64:1997;55-62.
17. Vardi J.R., Tadros G.H., Anselmo M.T., Rafla S.D. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet Gynecol. 80:1992;204-208.
18. Gitsch G., Friedlander M.L., Wain G.V., Hacker N.F. Uterine papillary serous carcinoma. A clinical study. Cancer. 75:1995;2239-2243.
19. Resnik E., Taxy J.B. Neoadjuvant chemotherapy in uterine papillary serous carcionoma. Gynecol Oncol. 62:1996;123-127.
20. Price F.V., Chambers S.K., Carcangiu M.L., Kohorn E.I., Schwartz P.E., Chambers J.T. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 51:1993;383-389.
21. Chambers J.T., Chambers S.K., Kohorn E.I., Carcangiu M.L., Schwartz P.E. Uterine papillary serous carcinoma treated with intraeperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide. Gynecol Oncol. 60:1996;438-442.
22. Thigpen T., Vance R.B., Khansur T. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix. Sem Oncol. 22(Suppl 12):1995;67-75.
23. Jeffrey J.F., Krepart G.V., Lotocki R.J. Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol. 67:1986;670-674.
24. Ward B.G., Wright R.G., Free K. Papillary carcinoma of the endometrium. Gynecol Oncol. 39:1990;347-351.
25. Carcangiu M.L., Chambers J.T. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium. Comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 14:1995;30-38.